Search research articles
Contact Us
Filters
Showing results (221-230 of 297) with videos related to
Page
of 30
Sort By:
Journal of Cell Science
|
September 17, 2025
Morphological reprogramming of primary cilia length mitigates the fibrotic phenotype in fibroblasts across diverse fibrotic conditions
Priyanka Verma, Bharat Yalavarthi, Swati Bhattacharyya, et al.
Plos One
|
November 10, 2017
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov, Grace-Hyun J Kim, Wendy Hayes, et al.
Rheumatology (Oxford, England)
|
May 18, 2022
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis
Christopher P Denton, Francesco Del Galdo, Dinesh Khanna, et al.
Journal of Psychosomatic Research
|
December 3, 2020
Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study
Yin Wu, Linda Kwakkenbos, Richard S Henry, et al.
Scientific Reports
|
July 2, 2017
Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
Roberta G Marangoni, Yuri Masui, Feng Fang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology
Emily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
Arthritis Research & Therapy
|
May 20, 2015
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
Roberta Goncalves Marangoni, Benjamin D Korman, Yannick Allanore, et al.
Journal of the American College of Cardiology
|
April 25, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
Vallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
The Journal of Investigative Dermatology
|
May 17, 2013
Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis
Monique Hinchcliff, Chiang-Ching Huang, Tammara A Wood, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 15, 2011
Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ
Manu Jain, G R Scott Budinger, Amy Lo, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 297) with videos related to
Sort By:
Page
of 30
Journal of Cell Science
|
September 17, 2025
Morphological reprogramming of primary cilia length mitigates the fibrotic phenotype in fibroblasts across diverse fibrotic conditions
Priyanka Verma, Bharat Yalavarthi, Swati Bhattacharyya, et al.
Plos One
|
November 10, 2017
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Viktor Martyanov, Grace-Hyun J Kim, Wendy Hayes, et al.
Rheumatology (Oxford, England)
|
May 18, 2022
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis
Christopher P Denton, Francesco Del Galdo, Dinesh Khanna, et al.
Journal of Psychosomatic Research
|
December 3, 2020
Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study
Yin Wu, Linda Kwakkenbos, Richard S Henry, et al.
Scientific Reports
|
July 2, 2017
Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
Roberta G Marangoni, Yuri Masui, Feng Fang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 8, 2019
Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology
Emily-Ann Butler, Murray Baron, Agnes B Fogo, et al.
Arthritis Research & Therapy
|
May 20, 2015
A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
Roberta Goncalves Marangoni, Benjamin D Korman, Yannick Allanore, et al.
Journal of the American College of Cardiology
|
April 25, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
Vallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
The Journal of Investigative Dermatology
|
May 17, 2013
Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis
Monique Hinchcliff, Chiang-Ching Huang, Tammara A Wood, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 15, 2011
Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ
Manu Jain, G R Scott Budinger, Amy Lo, et al.
Page
of 30